Perspective Therapeutics Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| BDX | Becton Dickinson and Co | Outperform |
9
|
$235.67 | $284.47 | 17.75% | 8 | $68.11B |
| EKTA B | Elekta AB (publ) | Hold |
18
|
kr80.35 | kr83.00 | -2.92% | 3 | kr30.26B |
| NWBO | Northwest Biotherapeutics | - |
7
|
$0.49 | $8.00 | -100.00% | 0 | $560.52M |
| ARAY | Accuray Inc | Buy |
11
|
$1.62 | $8.75 | 270.37% | 0 | $215.20M |
| CAPR | Capricor Therapeutics | Buy |
0
|
$5.30 | $13.50 | 239.62% | 1 | $166.97M |
| FBIO | Fortress Biotech | Buy |
11
|
$1.67 | $67.50 | 349.10% | 1 | $33.66M |
| PIRS | Pieris Pharmaceuticals | - |
9
|
$11.15 | $7.00 | -100.00% | 0 | $13.80M |
| ONTX | Onconova Therapeutics | Buy |
6
|
$0.68 | $11.50 | 929.41% | 0 | $13.75M |
| CYCC | Cyclacel Pharmaceuticals | Outperform |
5
|
$2.27 | $240.00 | 384.58% | 0 | $3.32M |